Puma Financial Statements From 2010 to 2025

PBYI Stock  USD 3.24  0.08  2.41%   
Puma Biotechnology financial statements provide useful quarterly and yearly information to potential Puma Biotechnology investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Puma Biotechnology financial statements helps investors assess Puma Biotechnology's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Puma Biotechnology's valuation are summarized below:
Gross Profit
166.1 M
Profit Margin
0.1314
Market Capitalization
164.7 M
Enterprise Value Revenue
0.598
Revenue
230.5 M
We have found one hundred twenty available trending fundamental ratios for Puma Biotechnology, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Puma Biotechnology recent fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 141 M. Enterprise Value is estimated to decrease to about 124.9 M

Puma Biotechnology Total Revenue

135.39 Million

Check Puma Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Puma Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 13.1 M, Other Operating Expenses of 177.1 M or Operating Income of 32.5 M, as well as many indicators such as Price To Sales Ratio of 0.68, Dividend Yield of 0.0 or PTB Ratio of 1.53. Puma financial statements analysis is a perfect complement when working with Puma Biotechnology Valuation or Volatility modules.
  
Check out the analysis of Puma Biotechnology Correlation against competitors.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.

Puma Biotechnology Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets168.9 M213.3 M183.3 M
Slightly volatile
Cash69 M69.2 M74.8 M
Pretty Stable
Cash And Short Term Investments74.1 M101 M80.4 M
Pretty Stable
Common Stock Total Equity4.3 K4.5 K22.3 K
Slightly volatile
Common Stock Shares Outstanding33.9 M49.1 M35.9 M
Slightly volatile
Liabilities And Stockholders Equity168.9 M213.3 M183.3 M
Slightly volatile
Other Stockholder Equity806.5 M1.4 B875.2 M
Slightly volatile
Total Liabilities110 M121.2 M113.2 M
Slightly volatile
Total Current Assets128.9 M147.7 M139.9 M
Slightly volatile
Common Stock4.3 K4.5 K22.3 K
Slightly volatile
Total Current Liabilities59.7 M96.1 M58 M
Slightly volatile
Accounts Payable5.2 M5.5 M11.2 M
Very volatile
Other Current Liabilities44.9 M39.7 M38.5 M
Slightly volatile
Other Liabilities7.6 M14.7 M7.4 M
Slightly volatile
Property Plant And Equipment Net8.2 M5.1 M7.1 M
Slightly volatile
Non Current Assets Total51.4 M65.7 M44.2 M
Slightly volatile
Non Currrent Assets Other2.3 M2.4 M5.5 M
Very volatile
Other Assets0.860.9M
Pretty Stable
Non Current Liabilities Total23.8 M25.1 M53.4 M
Slightly volatile
Capital Surpluse952.6 M1.6 B899.6 M
Slightly volatile
Other Current Assets8.3 MM7.1 M
Slightly volatile
Deferred Long Term Liabilities811.7 K854.5 K1.8 M
Very volatile
Property Plant And Equipment Gross9.1 M13 M7.8 M
Slightly volatile
Property Plant Equipment1.3 M1.3 M3.1 M
Pretty Stable
Net Receivables26.2 M32 M20.5 M
Slightly volatile
Short and Long Term Debt Total83.6 M52.4 M78.7 M
Slightly volatile
Long Term Debt Total104.8 M111.7 M76.7 M
Slightly volatile
Net Invested Capital140.2 M159.2 M117 M
Slightly volatile
Short and Long Term Debt39.1 M45.3 M38.6 M
Slightly volatile
Net Working Capital48.7 M51.5 M54.5 M
Very volatile
Short Term Debt27.1 M50.9 M33.9 M
Slightly volatile
Capital Stock4.9 K5.8 K4.3 K
Slightly volatile
Capital Lease Obligations13.6 MM21.5 M
Slightly volatile
Non Current Liabilities Other1.7 M1.8 M25.3 M
Slightly volatile
Current Deferred RevenueM5.3 M63.8 M
Slightly volatile

Puma Biotechnology Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses177.1 M199.5 M192.2 M
Slightly volatile
Selling General Administrative67 M80.7 M69 M
Slightly volatile
Depreciation And Amortization12.1 M11.5 M4.9 M
Slightly volatile
Research Development84.7 M54.9 M98 M
Very volatile
Interest IncomeM4.7 M1.6 M
Slightly volatile
Reconciled Depreciation9.6 M11.5 M6.2 M
Slightly volatile
Non Recurring5.6 M6.3 M6.9 M
Slightly volatile

Puma Biotechnology Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow71.9 M71.3 M78.1 M
Pretty Stable
Sale Purchase Of Stock10.5 M11 M54.4 M
Slightly volatile
Depreciation5.8 M11.5 MM
Slightly volatile
Change To Netincome20.6 M21.7 M44.7 M
Very volatile
Stock Based Compensation7.8 M8.2 M39 M
Very volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Days Sales Outstanding65.5650.696989.6426
Slightly volatile
Average Payables268.7 K255.9 K248.8 K
Slightly volatile
Stock Based Compensation To Revenue0.0340.03582.0261
Slightly volatile
Capex To Depreciation0.00460.004910.4758
Slightly volatile
Inventory Turnover7.637.38246.4548
Slightly volatile
Days Of Inventory On Hand52.9149.44285.2128
Slightly volatile
Payables Turnover12.2811.69073.4188
Slightly volatile
Sales General And Administrative To Revenue0.330.35012.1469
Slightly volatile
Cash Per Share2.222.07543.2645
Slightly volatile
Days Payables Outstanding29.6631.22143.7 K
Slightly volatile
Intangibles To Total Assets0.210.23970.2692
Slightly volatile
Current Ratio1.461.53638.4714
Slightly volatile
Receivables Turnover7.987.19975.3789
Slightly volatile
Graham Number5.415.14961.2565
Slightly volatile
Capex Per Share0.00110.00120.1818
Very volatile
Interest Debt Per Share1.291.33231.4918
Slightly volatile
Debt To Assets0.230.24550.3703
Slightly volatile
Short Term Coverage Ratios0.730.76515.893
Slightly volatile
Operating Cycle118100175
Slightly volatile
Days Of Payables Outstanding29.6631.22143.7 K
Slightly volatile
Ebt Per Ebit0.960.77831.1745
Very volatile
Long Term Debt To Capitalization0.01520.0160.5609
Very volatile
Total Debt To Capitalization0.340.36240.612
Slightly volatile
Quick Ratio1.371.44568.2946
Slightly volatile
Net Income Per E B T0.951.25631.1212
Pretty Stable
Cash Ratio0.680.72027.1828
Slightly volatile
Days Of Inventory Outstanding52.9149.44285.2128
Slightly volatile
Days Of Sales Outstanding65.5650.696989.6426
Slightly volatile
Debt Ratio0.230.24550.3703
Slightly volatile
Gross Profit Margin0.870.72060.7979
Pretty Stable

Puma Biotechnology Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap141 M148.4 M1.2 B
Slightly volatile
Enterprise Value124.9 M131.5 M1.2 B
Slightly volatile

Puma Fundamental Market Drivers

Forward Price Earnings7.722
Cash And Short Term Investments101 M

Puma Upcoming Events

7th of March 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Puma Biotechnology Financial Statements

Investors use fundamental indicators, such as Puma Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Puma Biotechnology's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue5.3 MM
Total Revenue230.5 M135.4 M
Cost Of Revenue64.4 M67.6 M
Stock Based Compensation To Revenue 0.04  0.03 
Sales General And Administrative To Revenue 0.35  0.33 
Research And Ddevelopement To Revenue 0.24  0.23 
Revenue Per Share 4.74  3.66 
Ebit Per Revenue 0.13  0.13 

Currently Active Assets on Macroaxis

When determining whether Puma Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Puma Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puma Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puma Biotechnology Stock:
Check out the analysis of Puma Biotechnology Correlation against competitors.
For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.585
Earnings Share
0.62
Revenue Per Share
4.737
Quarterly Revenue Growth
(0.18)
Return On Assets
0.0872
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.